To evaluate the therapeutic effect of mesenchymal stem cells (MSCs)inthe chronic interstitial cystitis (IC) rat model. METHODS: To make IC rat model female 8-week-old SpragueDawley ratswere given protamine sulfate (PS, 10mg) and lipopolysaccharide (LPS, 750ug) weekly for 5 weeks. One week after final administration of PS/LPS, rat were divided into five groups: sham (n¼10); PBS (n¼10, IC); 0.25 million of MSCs (n¼10, ICþMSCs); 0.5 million of MSCs (n¼10, ICþMSCs); 1 million of MSCs (n¼10, ICþMSCs) were injected into the submucosal layer of the anterior wall and dome of the bladder.The therapeutic effect of MSCs was examined by awakecystometry,histological and gene expression analysis 1 week after MSCs injection.
INTRODUCTION AND OBJECTIVES:
To evaluate the therapeutic effect of mesenchymal stem cells (MSCs)inthe chronic interstitial cystitis (IC) rat model. METHODS: To make IC rat model female 8-week-old SpragueDawley ratswere given protamine sulfate (PS, 10mg) and lipopolysaccharide (LPS, 750ug) weekly for 5 weeks. One week after final administration of PS/LPS, rat were divided into five groups: sham (n¼10); PBS (n¼10, IC); 0.25 million of MSCs (n¼10, ICþMSCs); 0.5 million of MSCs (n¼10, ICþMSCs); 1 million of MSCs (n¼10, ICþMSCs) were injected into the submucosal layer of the anterior wall and dome of the bladder.The therapeutic effect of MSCs was examined by awakecystometry,histological and gene expression analysis 1 week after MSCs injection.
RESULTS: IC rat groupexhibited irregular voiding frequency, decreased inter-contraction intervals, micturition volume and increased residual volume. A single injection of MSCs significantly improved most of voiding parameters by increased the inter-contraction interval, increased micturition volume and decreased residual volume. The bladder of IC group rats were characterized with severe denudated urothelium with inflammation, increased mastcell infiltration and paralleled with down-regulation of Wnt-8a, Wnt-8b and Wnt-11. MSCs therapy significantly upregulatedShh and Wnt family genes (Smo, Wnt5a, Wnt8a, Wnt8b, Wnt10a, and Wnt11) as well as their downstream growth factors (Igf1, Igf2) which were characteristically downregulated in bladders of the LPS-IC group. A single transplantation of 1X106 MSCs (LPS-IC þ MSCs group) significantly ameliorated thesedefective voiding parameters.Of note, a single injection of MSCs significantly not only improved the bladder voiding parameters but also reversed the histological and gene expression alternations characteristic for IC bladder.
CONCLUSIONS: We demonstrate that MSC therapy have therapeutic effect to repair voiding function and regenerate denudated urothelium and stabilize mast cell infiltration in the most proper IC rat model. This study was to explore cell mobilization as a major mechanism underlying stem cell efficacy is tissue regeneration.
METHODS: Adult female cynomolgus monkeys (NHPs) with induced chronic urinary sphincter deficiency and partial bone marrow transplantation with GFP-transduced cells, underwent sphincter injections of autologous M-cherry-transduced skeletal muscle precursor cells (skMPCs) (n¼6), or the cell mobilizing chemokine CXCL12 (n¼6). Maximal resting and pudendal nerve stimulated urethral pressures (MUP) were measured monthly for 6 months, followed by quantitative multiplex/multispectral immunohistochemical analysis of the urinary sphincter complex.
RESULTS: Injections of CXCL12, but not skMPCs, restored resting and pudendal nerve stimulated MUP values to baseline levels. There were few (< 2% of nucleated cells) skMPCs seen in the sphincter complex 6 months post injection. CXCL12, but not skMPC, injections increased the muscle content (smooth and striated), innervation (somatic and adrenergic) and vascularization to that measured in normal urinary sphincters (n¼6 NHPs). Importantly, CXCL12, but not skMPC, injections resulted in greater numbers of BMCs found in the sphincter complex. These BMC origin cells were found in all areas of the sphincter complex (muscle, sub-mucosa and urothelium). They were co-localized in pudendal and adrenergic innervation and were found and integrating with and expressing endothelial markers within the neovascularization. They also expressed markers for smooth and striated muscle cells and expressed markers for muscle cells and urothelium.
CONCLUSIONS: In contrast with results of preclinical studies reporting almost complete restoration of sphincter function in animal models of acute sphincter dysfunction, cell therapies have been only modestly effective in treating women with chronic stress urinary incontinence (SUI). This could be associated with minimal integration and cell mobilization properties of cells in chronic SUI. In contrast, stimulation of cell mobilization (in this case with CXCL12) may represent a viable treatment target for restoring urological tissues in women with chronic urinary sphincter dysfunction.
Source of Funding: National Institutes of Health R01 DK 083688 "Regeneration of the Lower Urinary Tract in Nonhuman Primates"
PD33-04 URETHRAL SPHINCTER REGENERATION BY THREE-DIMENSIONAL BIO-FABRICATED AUTOLOGOUS ADIPOSE-DERIVED CELL STRUCTURE IN RABBITS
Sudha Silwal Gautam*, Tetsuya Imamura, Matsumoto, Japan; Mitsuru Shimamura, Tokyo, Japan; Tomonori Minagawa, Takashi Nagai, Manabu Ueno, Tetsuichi Saito, Masaki Nakazawa, Teriyuki Ogawa, Osamu Ishizuka, Matsumoto, Japan INTRODUCTION AND OBJECTIVES: Introduction and Objective: Previously, we have reported that implantation of single autologous adipose-derived mesenchymal stem cells (AdMSCs) into cryo-injured urethra could restore structure and function. However, the major issue with implantation of single cell-suspension was low survival rates. Therefore, the present study was designed to enhance the therapeutic potential of AdMSCs by delivering it into three-dimensional (3D) biofabricated structures.
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